Cumulative incidence of VTE in transplant-eligible and -noneligible patients treated in Myeloma IX and XI clinical trials. VTE cumulative incidence function curves for (A) Myeloma IX trial transplant-eligible and (B) transplant-ineligible pathways and (C) Myeloma XI trial transplant-eligible, (D) transplant-eligible including KCRD, and (E) transplant-ineligible pathways.